Skip to content

Comparison of the treatment of lateral epicondylitis in 0.5% lidocaine with low dose steroid injection and type1 collagen with low dose injection

Comparison of the treatment of lateral epicondylitis in 0.5% lidocaine with low dose steroid injection and type1 collagen with low dose injection

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0012078
Enrollment
400
Registered
2026-06-05
Start date
2026-05-14
Completion date
Unknown
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Seol Physical medicine and Rehabilitation clinic
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Adult patients aged 19 to 90 years Patients with a documented history of lateral epicondylitis (ICD-10: M77.1) Patients with complete baseline Visual Analog Scale (VAS) scores and Patient-Rated Tennis Elbow Evaluation (PRTEE) records prior to injection therapy Patients with available medical records at the scheduled post-treatment follow-up time points

Exclusion criteria

Exclusion criteria: Patients with unclear or undocumented medication information (e.g., ingredients, dosage) in their medical records Patients who received concomitant steroid injections in joints other than the elbow during the study period Patients who received concurrent Platelet-Rich Plasma (PRP) injection therapy during the study period Patients who underwent concurrent surgical treatment for lateral epicondylitis during the study period

Design outcomes

Primary

MeasureTime frame
Change in Visual Analog Scale (VAS) and Patient-Rated Tennis Elbow Evaluation (PRTEE) scores from baseline to the post-treatment follow-up time points

Secondary

MeasureTime frame
size of tendon tear and spur

Countries

Korea, Republic of

Contacts

Public ContactPyong-Hwa Seol

The Catholic University of Korea, Songeui Campus

sultaeng@hanmail.net+82-31-595-3675

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Jun 11, 2026